Carlyle Group Inc vs Smith & Nephew plc — how do they compare? Carlyle Group Inc trades at $48.27 (market cap $17.23B), while Smith & Nephew plc trades at $30.05 (market cap $12.54B). The key difference: Carlyle Group Inc is the larger of the two by market cap, and Carlyle Group Inc pays the higher dividend (2.9%). Which is the better fit depends on your goals.
| CG | SNN | |
|---|---|---|
Market Cap | $17.23B | $12.54B |
Sector | Financials | Health |
52-Week High | $69.35 | $38.70 |
52-Week Low | $40.52 | $28.73 |
Dividend Yield | 2.9% | 2.65% |
Enterprise Value | — | $15.57B |
Trailing returns across standard periods
The Carlyle Group is one of the world's largest alternative-asset managers, with $376.4 billion in total assets under management, including $259.6 billion in fee-earning AUM, at the end of June 2022. The company has three core business segments: private equity, which includes private equity, real estate, infrastructure and natural resources funds (accounting for 41% of fee-earning AUM and 65% of base management fees during 2021), global credit (45% and 24%) and investment solutions (14% and 11%). The firm primarily serves institutional investors and high-net-worth individuals. Carlyle operates through 29 offices across five continents, serving close to 2,700 active carry fund investors from 95 countries.
Read more on CG →Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →